WO1992016652A1 - Sondes d'acide nucleique utilisees pour la detection de mycobacterium tuberculosis - Google Patents

Sondes d'acide nucleique utilisees pour la detection de mycobacterium tuberculosis Download PDF

Info

Publication number
WO1992016652A1
WO1992016652A1 PCT/CA1991/000094 CA9100094W WO9216652A1 WO 1992016652 A1 WO1992016652 A1 WO 1992016652A1 CA 9100094 W CA9100094 W CA 9100094W WO 9216652 A1 WO9216652 A1 WO 9216652A1
Authority
WO
WIPO (PCT)
Prior art keywords
tuberculosis
probe
labeled
dna
biological sample
Prior art date
Application number
PCT/CA1991/000094
Other languages
English (en)
Inventor
John A. Smith
Manuel Altamirano
Original Assignee
The University Of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University Of British Columbia filed Critical The University Of British Columbia
Priority to CA 2106869 priority Critical patent/CA2106869A1/fr
Priority to JP50563991A priority patent/JPH06505143A/ja
Priority to EP19910906228 priority patent/EP0579597A1/fr
Priority to PCT/CA1991/000094 priority patent/WO1992016652A1/fr
Publication of WO1992016652A1 publication Critical patent/WO1992016652A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

Definitions

  • the present invention relates generally to the field of medical diagnostics and, more specifically, to DNA sequences suitable for generating polypeptides and DNA or RNA hybridization probes, as well as a method for identifying the presence of M. tuberculosis in a biological sample.
  • Tuberculosis is an infectious disease which has affected civilization since ancient times.
  • the World Health Organization has estimated that at least 30 million people are affected by tuberculosis. Additionally, there are about 10 million new cases each year, and a mortality rate of about 3 million per year.
  • the causative agent of tuberculosis is a slender, straight or slightly bent rod with rounded ends.
  • the bacilli vary in length from 1 to 4 ⁇ m and in width from 02 to 0.5 ⁇ m, are acid-fast, nonmotile, nonsporogenous, and nonencapsulated.
  • Mycobacteria in general, are characterized by their acid-fastness, which is due to high lipid content and physical integrity of the cell wall. Mycobacteria may be characterized microscopically after staining with acid-fast stains such as Ziehl-Neelsen, Kinyoun or Auramine-O stains.
  • the time required to identify M. tuberculosis may be reduced with the radiometric determination method of BACTEC (Johnston Laboratories, Inc., Towson, Md.).
  • the BACTEC radiometric blood culture system was adapted for the detection of mycobacteria. Briefly, bacteria other tha* mycobacteria are cleared from the sample with 2% NaOH-N-acetyl-L-cysteine. Samples are then grown on Middlebrook 7H12 medium containing 14 C palmitic acid. At the same time, another aliquot of the clinical sample is inoculated in a BACTEC bottle containing NAP -nitro-o-acetylamino- ⁇ -hydrojg ropiophenone) which inhibits the growth of M.
  • tuberculosis The samples are tested twice weekly on a BACTEC 460, which detects the production of ⁇ C ⁇ 2 due to the metabolism of **C palmitic acid, and which also calculates a growth index (GI). When the GI reaches 100, a sample of the vial content is stained with Auramine-O to confirm the presence of acid-fast bacilli. Thus, presence of M. tuberculosis may be confirmed using the BACTEC method based upon the GI, the lack of growth in NAP, and presence of acid-fast bacilli. Although faster than conventional culture methods, this method is still disadvantageous because it can take from 3 to 43 days to confirm the presence of M. tuberculosis. Additionally, this method is disadvantageous because it requires the use of dangerous radioactive isotopes in clinical laboratories, which are generally not properly equipped to handle such isotopes.
  • M. tuberculosis Another more recent diagnostic method for M. tuberculosis is available from Gen-Probe, San Diego, California. This method provides a probe which is an 12 ⁇ I labeled oligonucleotide made from the sequence of a gene that encodes M. tuberculosis ribosomal RNA Samples are prepared by removing the colonies to be tested from 4-week old cultures, and sonicating them to break open the cells. The radiolabeled probe is added, followed by successive washes to remove unbound probe. Confirmation of M. tuberculosis is based upon the presence of bound probes, which may be detected due to their radiolabeling.
  • a second disadvantage is the use of radioactive iodine in a clinical laboratory.
  • the present invention provides a rapid test which identifies the presence of M. tuberculosis in a either a laboratory culture or clinical sample, without requiring the use of radioactive isotopes.
  • other related advantages are provided.
  • the present invention provides a labeled probe comprising at least a portion of the nucleotide sequence of Figure 2 from nucleic acid number 1 to nucleic acid number 323, the probe being capable of specifically hybridizing to nucleic acids from M. tuberculosis.
  • a portion of a nucleotide sequence includes at least 14 nucleotides.
  • the labeled probe is selected from the group consisting of 32 P-dCIP, biotin-dATP, and digoxigenin-dUTP.
  • a method for detecting the presence of M. tuberculosis in a biological sample comprising the steps of: (a) treating cells contained within the biological sample to expose cellular nucleic acids; (b) incubating the cellular nucleic acids with a labeled M. tuberculosis specific probe comprising at least a portion of the nucleotide sequence of Figure 2 from nucleic acid number 1 to nucleic acid number 323, under conditions and for a time sufficient for hybridization to occur; and (c) detecting the presence of the hybridized, labeled M. tuberculosis specific probe.
  • a method for detecting the presence of M comprising the steps of: (a) treating cells contained within the biological sample to expose cellular nucleic acids; (b) incubating the cellular nucleic acids with a labeled M. tuberculosis specific probe comprising at least a portion of the nucleotide sequence of Figure 2 from nucleic acid number 1 to nucleic acid number 323, under conditions and for
  • tuberculosis in a biological sample comprising the steps of: (a) treating cells contained within the biological sample to expose cellular nucleic acids; (b) amplifying a selected cellular nucleic acid sequence; (c) incubating the amplified cellular nucleic acid sequence with a labeled M. tuberculosis specific probe comprising at least a portion of the nucleotide sequence of Figure 2 from nucleic acid number 1 to nucleic acid number 323, under conditions and for a time sufficient for hybridization to occur; and (c) detecting the presence of the hybridized, labeled M. tuberculosis specific probe.
  • the cells contained within the biological sample are immobilized onto a solid support which is preferably prehybridized.
  • a labeled probe comprising at least a portion of the nucleotide sequence of Figure 1 from nucleic acid number 1 to nucleic acid number 959, the probe being capable of specifically hybridizing to nucleic acids from M. tuberculosis.
  • This probe may be utilized within various aspects of the present invention as described above.
  • Figure 1 illustrates the nucleotide sequence of the 959 base pair insert from clone ASK-58.
  • Figure 2 illustrates the nucleotide sequence of the 323 base pair insert from clone ASK-58-4.
  • RNA hybridization probes as well as a method for the rapid detection of as few as two M. tuberc losis organisms within a biological sample are provided.
  • organisms in the M. tuberculosis complex including M. mi ro . M. afncanum, M. bovis, and M. bovis BCG
  • biological samples include cell cultures and clinical samples including, among others, biological fluids such as sputum, urine, gastric fluid, cerebrospinal fluid, surgically excised tissues, and histological tissue sections.
  • M. tuberculosis is available in culture from many sources, including, among others, the American Type Culture Collection (ATCC), Rockville, Maryland, U.S .
  • M. tuberculosis may be cultured in any media known in the art capable of growing mycobacteria, including egg-potato based medias (e.g., Lowenstein-Jensen), or agar based medias (e.g., Middlebrook 7H-10). These medias are available from PML Microbiologicals, Tualatin, Oregon.
  • the culture should be grown in an atmosphere of about 5%-10% CO2.
  • Particularly preferred conditions for growing M. tuberculosis include growth in Middlebrook 7H-9 broth supplemented with oleic acid, albumin, dextrose, and catalase (OADC, Difco, Gaithersburg, Md.), incubation in an atmosphere of about 5% CO2, and a temperature of about 37°C. Due to its very slow growth rate, between 3 and 6 weeks are required to grow a culture of M. tuberculosis. The mycobacteria are then removed from culture, and treated so as to liberate DNA. If the mycobacteria are grown in broth, cycloserine is added 24 hours before harvesting.
  • the culture is heat inactivated and then centrifuged to pellet the mycobacteria.
  • the cells are resuspended and lysed by any of a number of methods well known to those of skill in the art (see Sambrook et al., Molecular Cloning: A Laboratory Manual. 2nd ed., Cold Spring Harbor Laboratory Press, pp. 1.34-1.39, 1989).
  • Particularly preferred is the use of sodium dodecyl sulfate (SDS) and lysozyme to lyse the bacteria, followed by phenol extraction, ethanol precipitation, and treatment with TI RNase and RNase A in order to purify the DNA.
  • SDS sodium dodecyl sulfate
  • lysozyme to lyse the bacteria
  • the mycobacterial DNA is then fractionated.
  • restriction enzymes well known in the art which are capable of digesting the DNA, for example, Eco RI.
  • DNA fractions of the appropriate size may be selected through the use of agarose gel electrophoresis followed by electroelution. It is preferred that the mycobacterial DNA fractions be about 200 to 4,000 b.p. in length, and more ideally, between about 500 and 3,000 b.p. in length.
  • the same restriction enzymes used to digest mycobacterial DNA are also used to digest plasmid DNA, thus allowing insertion and ligation of the mycobacterial DNA into the plasmid through the use of cohesive termini.
  • the digested plasmid and mycobacterial DNA fractions of the appropriate size may then be ligated with T4 ligase, and transfected into E. coli using procedures well known in the art Any of the plasmids well known in the art may be used as a vector for the M. tuberculosis digests, although plasmid pT7T3 18U (Pharmacia LKB Biotechnology Inc., Piscataway, N J.) is particularly preferred.
  • This plasmid has ampicillin resistance and .-galactosidase genes, T3 and T7 transcriptional promoters, and sequences for the universal and reverse primers which allow double stranded DNA sequencing.
  • this plasmid has the polycloning site of bactenophage M13 and the Fl origin, which allows the production of sequenceable single stranded DNA from the plasmid.
  • Transfection of E coli with this plasmid results in colonies which can grow on media containing ampicillin.
  • transfected E. coli which contain plasmids with DNA inserts may be identified by the formation of white colonies on two times yeast tryptone media (2YT) with IPTG and BlueGal. Insertion of a foreign DNA fragment into the polycloning site of the plasmid results in white colonies on 2YT plates due to the production of an amino- terminal fragment that is not capable of ⁇ -complementation (see Sambrook et al., supra at pp.
  • Colonies which contain plasmids with appropriate inserts may then be screened using conventional techniques. Particularly preferred is the use of hybridization via methods which are well known in the art (see, for example, Sambrook et al., supra at pp. 1.90-1.104). Briefly, white colonies are replica plated and screened for positives with ⁇ 2 labeled nick translated M. tuberculosis DNA, and for negatives with ⁇ 2p labeled nick translated DNA from mycobacteria other than tuberculosis (MOTT), including M. avium-mtracellulare, M. kansasu, M. scrofulaceum, M. chelonae and M. marinium. The mycobacteria other than tuberculosis may be grown using media well known in the art, and the DNA purified using methods as described above for M tuberculosis.
  • MOTT mycobacteria other than tuberculosis
  • M. tuberculosis and not to other mycobacteria may then be accomplished in order to ascertain the size of the insert and to ensure its specificity.
  • Particularly preferred is the miniprep alkali method (see Sambrook, supra at pp. 125 to 1.28).
  • the plasmids are digested with the same restriction enzyme as used for insertion, and run on a gel so that the insert size can be determined.
  • the DNA may be transferred to nylon membranes using the transfer alkali method in a VacuGene 1 " apparatus (LKB-Pha ⁇ nacia, Bromma, Sweden). The DNA insert which is bound to the nylon membrane is then tested for hybridization to labeled
  • M. tuberculosis DNA and mycobacteria other than tuberculosis may be used to develop DNA sequences suitable for hybridization probes. Additionally, as discussed below, open reading frames of the DNA sequence may be used to generate polypeptides.
  • the insert containing clone may be further characterized. Briefly, M. tuberculosis and MOTT DNA is digested with the same restriction enzyme as used above, preferably Eco RI. Thereafter, the digested mycobacterial DNA is analyzed by agarose gel electrophoresis. The DNA is then transferred from the gel to a nylon membrane and is tested for hybridization with the radiolabeled insert
  • Positive clones may then be grown on a larger scale, in order to prepare large quantities of the plasmid.
  • Methods for preparing large scale preparations of plasmid DNA are well known in the art. (See, for example, Sambrook et al., supra at pp. 133-1.39.) Briefly, the E. coli is grown using any media capable of supporting the growth of the bacteria. Particularly preferred is Terrific Broth (see Sambrook et al., supra at p. A2, 1989). The cells may then be lysed and the DNA extracted and purified as described above. Retrieval of the insert in the plasmid may then be accomplished.
  • the plasmid is digested with the same restriction enzyme as was initially used to fractionate and insert the M. tuberculosis DNA into the plasmid.
  • the insert is then isolated from the other plasmidic DNA by agarose gel electrophoresis.
  • the isolated DNA insert may be further fractionated using a different restriction enzyme, such as Bam HI, and once again selected for its specificity to M. tuberculosis with the above hybridization and cloning methods. Additionally, the specificity of the insert for M tuberculosis may be confirmed as described above.
  • a different restriction enzyme such as Bam HI
  • DNA insert Once the DNA insert has been isolated it may be sequenced using any of the methods well known in the art. Particularly preferred are the enzymatic method of Sanger et al. ("DNA Sequencing with Chain-Terminating Inhibitors," Proc. Nat'l. Acad. Sci. 24:5463, 1977), and the chemical degradation method of Maxam and Gilbert ("A New Method for Sequencing DNA,” Proc. Nat'l. Acad. S ⁇ L 24:560, 1977).
  • the DNA sequence of the insert may be used to: (I) generate polypeptides, or (II) develop hybridization probes and amplification primers suitable for detecting M. tuberculosis DNA or RNA in biological samples,
  • the DNA sequence of the insert is analyzed for open reading frames. Open reading frames are determined by searching the DNA sequences for initiation codons such as AUG. Sequences following initiation codons may be transcribed and translated by the cell to express a polypeptide. Thus, DNA sequence found within an open reading frame may be used to generate polypeptides, either by synthetically constructing the polypeptides, or, by recombinantly expressing the polypeptide from a host cell. The peptide may then be purified using techniques well known in the art, such as High Pressure Liquid Chromatography (HPLC). The purified polypeptide may be used for several purposes.
  • HPLC High Pressure Liquid Chromatography
  • the polypeptide may be used as a source of antigen to generate monoclonal or polyclonal antibodies by methods well known in the art for use within an Enzyme-Linked Immunosorbant Assay (ELISA).
  • ELISA Enzyme-Linked Immunosorbant Assay
  • Such an assay may be used to test the serum of individuals for the presence of antibodies against the tuberculosis antigens.
  • polypeptide for intradermal injection, in order to test for previous immunological exposure to M. tuberculosis.
  • polypeptide is purified and prepared for intradermal administration using techniques well known in the art Similar to the PPD test a rash which develops in the area surrounding the intradermal injection site indicates an immune response to the polypeptide. Thus, a positive response indicates previous immunological exposure to M. tuberculosis.
  • DNA sequences derived from M. tuberculosis may also be used to develop primers for amplification, and probes for detecting M. tuberculosis DNA or RNA
  • probes for detecting M. tuberculosis DNA or RNA
  • probes are "capable of specifically hybridizing to M. tuberculosis DNA” if they hybridize under conditions of about 5 to 6 times SSC, and at a temperature of 64°C to 68°C. Particularly preferred conditions are about 6 X SSC (1M Nad) and 65°C.
  • the probes need not be perfectly complementary to the M. tuberculosis sequence to which they hybridize. As much as about 30% of the probe may be mismatched as compared to M. tuberculosis nucleic acid sequences, and nevertheless allow detection of the presence of M. tuberculosis. If an amplification system such as Q ⁇ replicase or Polymerase Chain Reaction (PCR) is used, the probe may be selected such that it is between the two primers used for amplification.
  • the probe may have as few as about 14 nucleotides, usually about 24 nucleotides, and as many as 323 or more nucleotides.
  • the probe may be chosen from a portion of the nucleotide sequence of Figure 2, from nucleic acid number 1, to nucleic acid number 323, or, alternatively, from a portion of the 959 b.p. insert of Figure 1.
  • the probes may be constructed and labeled using techniques well known in the art Shorter probes of, for example, 24 bases may be generated synthetically. Longer probes of about 75 to about 283 bases are preferably generated by Q ⁇ replicase or PCR amplification in the presence of the labeled precursors such as 32 P-dCTP, digoxigenin-dUTP or biotin-dATP. Probes of 323 bases or longer may be generated directly by growing a transfected cell, purifying the relevant sequence, and labeling the probe by the random primer method. Probes may be labeled with any detection system known in the art, including, among others, radioactive markers, fluorescent markers, enzymatic markers, and chromogenic markers.
  • Preferred labels include 32 P-dCIP, digoxigenin-dUTP, and biotin-dATP.
  • Digoxigenin-dUTP is particularly preferred because of its sensitivity, and because it allows detection of the target sequences without a radioactive label.
  • digoxigenin-dUTP is incorporated into a 24 base oligonucleotide probe through the use of terminal deoxynucleotidyl transferase.
  • the hybridization probe may be used directly to confirm the presence of either M. tuberculosis DNA or RNA in laboratory cell cultures using techniques well known to those of ordinary skill in the art. Briefly, the cells are treated to expose cellular nucleic acids as described above.
  • the cellular nucleic acids are then incubated with a labeled M. tuberculosis specific probe, under conditions and for a time sufficient for hybridization to occur, followed by the detection of the hybridized, labeled, M. tuberculosis specific probe.
  • M. tuberculosis In biological samples other than cell cultures, such as sputum, M. tuberculosis is present in only relatively few numbers. Thus, in order to enhance detection, it is preferred that an amplification system be used to increase the quantity of M. tuberculosis DNA or RNA Various methods are known in the art, including: RNA amplification (see Lizardi et al., Bio/Technology &1197- 1202, 1988); and DNA amplification with PCR (see Mullis et al., U.S. Patent No. 4,683,195; Mullis et al., U.S. Patent No.4,683-202; and Mullis et al., U.S. Patent No.4,800,159, which are incorporated herein by reference).
  • RNA amplification see Lizardi et al., Bio/Technology &1197- 1202, 1988
  • DNA amplification with PCR see Mullis et al., U.S. Patent No. 4,683,
  • Primers for DNA amplification with Taq polymerase should be selected from DNA sequences which are highly specific and form stable duplexes with the target sequence.
  • the primers should also be non-complementary, especially at the 3' end, should not form dimers with themselves or other primers, and should not form secondaiy structures or duplexes with other regions of the DNA
  • primers of about 24 nucleotides in length are preferred, and may be easily synthesized using techniques well known in the art
  • primers are chosen from both ends of the sequence, preferably from portions of the nucleotide sequence of Figure 2, from nucleic acid number 1 to nucleic acid number 323.
  • primers may also be chosen from other sequences within the 959 b.p. fragment of Figure 1.
  • biological samples such as sputum or laboratory cultures may be tested for the presence of M. tuberculosis.
  • the biological sample is a clinical sample, such as sputum
  • the first sample is first submitted to liquefaction, decontamination, concentration, (see Ratnam and March, Journal of Clinical Microbiology. 23_(3):582-585, 1986) and DNA extraction using any of a number of established procedures.
  • the concentrated sputum is brought up to a volume of 300 ⁇ l with TE buffer, followed by the addition of 300 mg of glass beads 200 microns in diameter (Sigma Chemical Co., St Louis, Mo.).
  • One mg of lysozyme is added and sufficient SDS is added to bring the sample to a final concentration of 1%.
  • the samples are incubated at 37°C for 60 minutes, followed by sonication at 70°C for 15 minutes.
  • the samples are phenol extracted, ethanol precipitated and treated with Tl RNase and RNase A. A second phenol extraction and ethanol precipitation may be performed to ensure purity.
  • the decontaminated and concentrated sputum is suspended in a final concentration of 0.1 M NaOH, 2 M NaCl and 0.5% SDS and incubated at 95 °C for 15 minutes. After phenol extraction, the DNA is ethanol precipitated and redissolved in H2O.
  • the selected cellular nucleic acid sequence from the purified sample is amplified with the above-described primers using techniques well known in the art Briefly, polymerase chain reaction is based on the use of a DNA polymerase from Thermus aquaticus (Taq polymerase) which is thermostable at 95°C.
  • a DNA sample is denatured at 95°C in order to generate single strand DNA.
  • Specific primers, as described above, are annealed at 37°C- 70°C, depending on the proportion of AT/GC of the primers.
  • the primers are extended at 72°C with Taq polymerase in order to generate the opposite strand to the template. These three steps constitute a cycle. After each cycle, the target DNA is doubled, resulting in at least 10 -fold increase in DNA after 25 cycles.
  • the amplified sample is then transferred to a solid support such as nylon membrane, and tested with a specific labeled probe as described above, for hybridization.
  • a solid support such as nylon membrane
  • the samples are transferred to a nylon filter using a Bio-Dot ⁇ apparatus (Bio-Rad, Richmond, Calif.).
  • the filter is then prehybridized for one hour using procedures well known in the art (see Sambrook et al., supra at p. A 1.102), and hybridized overnight with a digoxigenin-dUTP labeled 24 base oligonucleotide probe.
  • positive dot blots may be detected with an alkaline phosphatase conjugated anti-digoxigenin antibody, followed by awash of the filter and addition of a chromogenic substrate such as BOP/NBT (5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium).
  • a chromogenic substrate such as BOP/NBT (5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium).
  • RNA based amplification is an RNA based amplification (see Lizardi etal., Bio/Technologv 6:1197-1202, 1988; Kramer et al., Nature 222:401-402, 1989; and Lomeli et al., Clinical Chemistry 25(9):1826-1831, 1989; see also Kramer et al., U.S. Patent No. 4,786,600, which is incorporated herein by reference).
  • RNA amplification is based on the fact that some RNA bacteriophages (specifically, Q ⁇ ) replicate through the actions of an RNA-directed RNA polymerase.
  • This polymerase, *Q ⁇ replicase will replicate sequences which are embedded within its normal template (MDV-1), despite the additional length.
  • Techniques for amplifying a selected cellular nucleic acid sequence using Q ⁇ replicase are well known to one of ordinary skill in the art Briefly, cells within a biological sample are treated to expose cellular nucleic acids. A selected cellular nucleic acid sequence may then be amplified with Q ⁇ replicase. As above, the sequence may be selected either from a portion of the nucleotide sequence of Figure 2, from nucleic acid number 1 to nucleic acid number 323, or from a sequence of the 959 b.p. fragment of Figure 1. A radiolabeled probe may then be used to detect the presence of amplified RNA using methods as described above.
  • a probe is prepared which is complementary to a target nudeotide sequence which is selected from a portion of the nucleic add sequence of Figure 2.
  • the target is DNA and the probe contains labeled DNA on one end, from 1 to 4 RNA nucleotides near the center, and DNA on the other end which is capable of binding to a solid support
  • the probe is then incubated under hybridizing conditions to a sample, allowing the target sequence, if present to bind to the probe.
  • the mixture is then treated with a complex such as endoribonuclease H which deaves the RNA center. If the probe has not hybridized to the target sequence, the labeled DNA will separate from the DNA attached to the solid support Thus, when the solid support is removed from the reaction mixture, the loss of label may be detected.
  • a complex such as endoribonuclease H which deaves the RNA center.
  • Mycobacterium tuberculosis H37 Rv strain TMC 1 was obtained from the Trudeau Institute, Saranac Lake, New York U.S ⁇ . The mycobacteria were grown as a stationary culture in Middlebrook 7H9 broth supplemented with
  • Sorval SS34 rotor for 10 minutes. The pellet was resuspended in TE buffer and freshly prepared lysozyme (1 mg/ml), and incubated at 37°C for 60 minutes. SDS was added to make the solution 1%, followed by incubation for an additional hour. DNA from the lysed mycobacteria was then phenol extracted twice and ethanol predpitated. The DNA was treated with Tl RNase (1 unit per O.D.) plus
  • RNase A 100 ⁇ g/ml
  • the DNA solution was then made 35 M ammonium acetate and ethanol predpitated.
  • the DNA was predpitated by centrifugation at 15,000 x g, and resuspended in TE buffer to a final concentration of 1 mg/ml.
  • the purified M. tuberculosis DNA was digested with 10 U/ ⁇ g Eco RI, and run on a 0.7% agarose gel. Fragments between 200 and 4000 b.p. were electroeluted and purified with Geneclean 1* (Bio 101, La Jolla, Calif.). Plasmid pT7T3 18U (Pharmada) was also digested with Eco RI, dephosphorylated with bacterial alkaline phosphatase, and mixed with total or enriched Eco RI digested M. tuberculosis at a molar ratio of 3:1. The samples were ligated with T4 ligase at 26°C for 4 hours, and transfeded into E coli MN522. The cells were spread onto ampicillin plates with IPTG and BlueGal. White colonies were retrieved and screened for M. tuberculosis inserts. Screening of M. tuberculosis Inserts
  • avium- inraceUulare/M. scrofidaceum (MAIS). DNA was prepared by the above- described purification method, followed by 32 P-dCTP random primer labeling of the DNA Oligonucleotides were separated from the labeled DNA by spun- column chromatography using DNA grade Sephadex G-50 (Pha ⁇ nada, Uppsala, Sweden). (See also, Maniatis et al. Molecular Cloning, Coldspring Harbor Laboratory, p.466, 1982). The labeled DNA was denatured to single stranded form by incubation at 100°C for 10 minutes. The labeled DNA was used at a concentration of 10" CPM/ml, and 160 ⁇ l were used for each square centimeter of filter.
  • Hybridization was performed in a solution containing 10% dextransulfate, 1 M NaCl, 1% SDS and 100 ⁇ g/ml denatured salmon testes DNA at an incubation temperature was 65°C for 16 hours. After hybridization, the filters were washed with 6 X SSPE, 05% SDS for 15 minutes at room temperature; a second wash was performed with 1 X SSPE, 1% SDS at 37°C for 30 minutes; the last wash was performed with 0.1% SSPE, 1% SDS at 65°C for 30 minutes. After the washes, the filters were allowed to dry at room temperature.
  • the filters were then autoradiographed on Kodak X-Omat RP 1 " film (Eastman Kodak, Rochester, N.Y.) and two intensifying screens (Dupont Cronex 1 ", Hi-Plus Dupont, Wilmington, Del.) at -70°C for 24 hours.
  • Colonies which were positive for M. tuberculosis and negative for MOTT were grown in 2YT media with ampicillin.
  • the plasmids were then isolated using the miniprep alkali method (see Sambrook, supra at pp. 1.25-128), digested with Eco RI and analyzed in a 0.7% agarose gel in order to determine the presence of an insert.
  • the insert was transferred to nylon membrane and hybridized with 3 P-dCTP random primer labeled M. tuberculosis DNA. After hybridization, the probe was removed and the filters were rehybridized with a mixture of M. avium- ⁇ ttraceuulare andilf. scrofulaceum.
  • a clonal colony was selected which contains an insert which hybridizes to M. tuberculosis DNA and not to MOTT.
  • the sequence of this clone (ASK 58) was determined, and is set forth in Figure 1.
  • ASK-58 has been deposited with the ATCC under accession number 68197.
  • the DNA was transferred to nylon membranes (Hybond-N 1* , Amersham) in a VacugeneTM apparatus (LKB-Pharmada, Bromma, Sweden) using 0.4 N NaOH, 15 M NaCl for 45 minutes at a pressure of 50 cm H2O.
  • the membrane was dried at room temperature, and then for 20 minutes at 80°C in a vacuum oven.
  • the membranes were hybridized with the purified insert of the clone, which was labeled with 32 P- dCTP by the random primer method. Only the sample of M. tuberculosis DNA generates a band at the level of the 959 b.p. area; the rest of the MOTT samples were negative.
  • the ASK-58 done was then grown in 1 liter volume using Terrific broth (Focus 9:2). Cells were lysed by the alkali method, phenol extracted, and ethanol predpitated. The samples were then treated with Tl RNase, pancreatic RNase and 35 M ammonium acetate. The final concentration was adjusted to l ⁇ g/ul.
  • the 959 b.p. insert of clone ASK-58 was digested with Bam HI, generating three fragments which were approximately 120, 323 and 460 b.p. in length. Each one of these fragments were labeled with 32 P-dCIP random primer and tested for hybridization against mycobacteria, including: M. tuberculosis, M. avium-intracelhilare and mycobarteria of the group skotochromogen and photochromogen. The 323 b.p. fragment hybridized only with M. tuberculosis.
  • the 323 b.p. fragment was subcloned in pT7T3 18U in the Eco RI, Bam HI site generating subclone ASK-58-4.
  • DNA purified from M. tuberculosis, as well as from MOTT were digested with Bam HI and Eco RI and electrophoresed in a 0.7% agarose gel.
  • a Southern blot was prepared and hybridized with random primer labeled insert from clone ASK-58-4 (323 b.p.); only M. tuberculosis hybridized generating a single band in the area of the 959 b.p.
  • 216 DNA samples purified from cultures were analyzed by hybridization using the insert of clone ASK-58-4 as probe.
  • the DNA sequence of ASK-58-4 (323 b.p.) was determined using the chain termination method and Sequenase ® , version 2.0 (modified T7 DNA polymerase) or with Taq Polyme ⁇ ase 1, ' (Taq Track 1 " sequencing system, Promega
  • primers suitable for amplification of M. tuberculosis DNA may be synthetically generated.
  • a 323 b.p. probe was prepared by growing clone ASK-58-4 and purifying the insert on an agarose gel. The insert was eluted off the gel and random primer labeled with digoxigenin-dUTP.
  • a 24 base oligonucleotide probe was prepared by growing clone ASK-58-4 and purifying the insert on an agarose gel. The insert was eluted off the gel and random primer labeled with digoxigenin-dUTP.
  • a 24 base oligonucleotide probe was prepared by growing clone ASK-58-4 and purifying the insert on an agarose gel. The insert was eluted off the gel and random primer labeled with digoxigenin-dUTP.
  • Sputum samples from patients suspected of having tuberculosis were obtained and submitted to liquefaction, decontamination and concentration using established procedures. Briefly, the sputum sample was decontaminated and concentrated, according to the method of Ratnam et al., Journal of Clinical Microbiology 22: 582-585, 1986, followed by heat inactivation at 95°C for 10 minutes. Next 100 ⁇ l of the treated sputum, 220 ⁇ l of TE buffer, and 50 ⁇ l of 33% lysozyme were transferred to an Eppendorf tube and incubated at 65°C for 15 minutes.
  • PCR product Ten percent of the PCR product was analyzed in a 2% agarose gel. The gel was stained with ethidium bromide in order to confirm the presence of a band of about 283 b.p. The remainder of the PCR product was brought to 0.2 N with the addition of NaOH, and incubated at room temperature for 10 minutes. The sample was then transferred to nylon membrane in a Bio-Dot ⁇ apparatus, and prehybridized for one hour. A 323 base pair probe was then prepared as described above, and labeled with digoxigenin-dUTP through the use of terminal deoxynucleotidyl transferase. The probe was allowed to hybridize overnight at 65°C.
  • the filters were then washed for 20 minutes in 6 X SSPE at room temperature, and then 3 times at 40°C with 6 X SSPE buffer.
  • the filters were readed for 30 minutes with alkaline phosphatase conjugated anti-digoxigenin, and washed.
  • the filters were then reacted with BOP/NTB. Positive samples develop a purple color
  • Ten positive and ten negative samples were prepared as described above. Briefly, the samples were first inactivated at 95°C for 10 minutes. One hundred microliters of the treated samples, 220 ⁇ l of TE buffer, and 50 ⁇ l of 33% lysozyme were then transferred to an Eppendorf tube and incubated at 65 * C for 15 minutes, followed by the addition of 100 ⁇ l of 5M sodium perchlorate and incubation at room temperature for 5 minutes. The sample was then extracted with chloroform/isoamyl alcohol and ethanol predpitated, and resuspended in 25 ⁇ l of TE buffer.
  • PCR Polymerase chain reaction
  • PCR product was brought to 0.2 N with the addition of NaOH, and incubated at room temperature for 15 minutes.
  • sample was loaded onto a microfiltration unit (either a CENTREX Disposable
  • Microfilter Unit (Schleicher & Schuell, Keene, New Hampshire), or a Ultrafree- MC W filter unit 0.4 ml Durapore (0.45 urn) (Millipore, Bedford, Mass.) and centrifuged for 10 minutes at 2000 rpm. The filter unit was then dryed in a vacuum oven 80°C for 10 minutes.
  • Detection of the probe was accomplished utilizing commerdally aavailable reagents (Genius w -system, Boehringer Mannheim, Indianapolis,
  • the probe was removed from the microfiltration unit by washing with 1 ml of buffer I (100 mM Tris-HCl, 150 mM
  • NTB Nitro Blue Tetrazolium Chloride
  • a NTB solution was prepared (112 ⁇ l NTB, 8.8 ⁇ l X-Phosphate, and
  • Lumi-Phos 530 contains 033 mM 4- methoxy-4-(3-phosphatephenyl)-spiro (l,2-dioxetane-3,2'-adamantine) disodium salt 750mM 2-amino-2-methyl-l-propanol buffer (pH 9.6), 0.88 mM MgC , 1.13 mM cethyltrimethyl ammonium bromide, and 0.035 mM fluorescein surfactant.
  • Luminenscence was deteded either by exposing the membrane to X-ray film (Kodak XAR) for 5 minutes, or by taking a picture with film such as Polaroid's fast film (Polaroid 612).
  • the probe had a specifidty and sensitivity of 100%.
  • ASK 58-4 The DNA sequence of done ASK 58-4 was analyzed to determine the presence of open reading frames.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

On décrit un procédé de détection de la présence de M. tuberculosis dans un échantillon biologique, qui consiste à: (a) traiter les cellules contenues dans l'échantillon afin d'exposer les acides nucléiques cellulaires; (b) incuber les acides nucléiques cellulaires avec une sonde marquée spécifique de M. tuberculosis dans des conditions et pendant une période garantissant que l'hybridation ait lieu; et (c) détecter la présence de la sonde marquée et hybridée spécifique de M. tuberculosis. On décrit aussi un polypeptide dérivé de M. tuberculosis.
PCT/CA1991/000094 1991-03-22 1991-03-22 Sondes d'acide nucleique utilisees pour la detection de mycobacterium tuberculosis WO1992016652A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA 2106869 CA2106869A1 (fr) 1991-03-22 1991-03-22 Sondes d'acides nucleiques utilisables pour la detection de mycobacterium tuberculosis
JP50563991A JPH06505143A (ja) 1991-03-22 1991-03-22 マイコバクテリウム・ツベルクローシスの検出に有用な核酸プローブ
EP19910906228 EP0579597A1 (fr) 1991-03-22 1991-03-22 Sondes d'acide nucleique utilisees pour la detection de mycobacterium tuberculosis
PCT/CA1991/000094 WO1992016652A1 (fr) 1991-03-22 1991-03-22 Sondes d'acide nucleique utilisees pour la detection de mycobacterium tuberculosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA1991/000094 WO1992016652A1 (fr) 1991-03-22 1991-03-22 Sondes d'acide nucleique utilisees pour la detection de mycobacterium tuberculosis

Publications (1)

Publication Number Publication Date
WO1992016652A1 true WO1992016652A1 (fr) 1992-10-01

Family

ID=4172880

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA1991/000094 WO1992016652A1 (fr) 1991-03-22 1991-03-22 Sondes d'acide nucleique utilisees pour la detection de mycobacterium tuberculosis

Country Status (4)

Country Link
EP (1) EP0579597A1 (fr)
JP (1) JPH06505143A (fr)
CA (1) CA2106869A1 (fr)
WO (1) WO1992016652A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998004711A2 (fr) * 1996-07-26 1998-02-05 Institut Pasteur Antigene desaturase de mycobacterium tuberculosis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0398677A2 (fr) * 1989-05-16 1990-11-22 President And Fellows Of Harvard College Sondes d'hybridation d'ADN pour l'identification de mycobactérie

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0398677A2 (fr) * 1989-05-16 1990-11-22 President And Fellows Of Harvard College Sondes d'hybridation d'ADN pour l'identification de mycobactérie

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
American Review of Respiratory Disease, volume 141, no. 4, April 1990, M. Altamirano et al.: " Fast and efficient method for the diagnosis of M. tuberculosis", see the whole article *
Molecular Microbiology, volume 3, no. 7, 1989, A.J. Hance et al.: "Detection and identification of mycobacteria by amplification of mycobacterial DNA", pages 843-849, see the whole article *
Tubercle, volume 69, 1988, C.C. Pao et al.: "The detection of mycobacterial DNA sequences in uncultured clinical specimens with cloned mycobacterium tuberculosis DNA as probes", pages 27-36, see the whole article *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998004711A2 (fr) * 1996-07-26 1998-02-05 Institut Pasteur Antigene desaturase de mycobacterium tuberculosis
WO1998004711A3 (fr) * 1996-07-26 1998-04-23 Pasteur Institut Antigene desaturase de mycobacterium tuberculosis
US6582925B1 (en) 1996-07-26 2003-06-24 Institut Pasteur Desaturase antigen of mycobacterium tuberculosis
US7071320B2 (en) 1996-07-26 2006-07-04 Institut Pasteur Desaturase antigen of mycobacterium tuberculosis
EP1972690A1 (fr) * 1996-07-26 2008-09-24 Institut Pasteur Antigène de désaturase de la tuberculose par mycobacterium
US7527788B2 (en) 1996-07-26 2009-05-05 Institut Pasteur Desaturase antigen of Mycobacterium tuberculosis

Also Published As

Publication number Publication date
JPH06505143A (ja) 1994-06-16
EP0579597A1 (fr) 1994-01-26
CA2106869A1 (fr) 1992-09-23

Similar Documents

Publication Publication Date Title
Mangiapan et al. Sequence capture-PCR improves detection of mycobacterial DNA in clinical specimens
US4358535A (en) Specific DNA probes in diagnostic microbiology
Jou et al. Single-tube, nested, reverse transcriptase PCR for detection of viable Mycobacterium tuberculosis
Song et al. Detection of Salmonella typhi in the blood of patients with typhoid fever by polymerase chain reaction
Buck et al. Rapid, simple method for treating clinical specimens containing Mycobacterium tuberculosis to remove DNA for polymerase chain reaction
Kocagöz et al. Detection of Mycobacterium tuberculosis in sputum samples by polymerase chain reaction using a simplified procedure
JP2798499B2 (ja) 感染症診断用プローブ
Folgueira et al. Detection of Mycobacterium tuberculosis DNA in clinical samples by using a simple lysis method and polymerase chain reaction
Piersimoni et al. Comparative evaluation of two commercial amplification assays for direct detection of Mycobacterium tuberculosis complex in respiratory specimens
EP0232085B1 (fr) Sonde du campylobacter
US7270982B2 (en) Helicobacter pylori antigens in blood
EP0619375B1 (fr) Détection et identification de mycobactéries
US5837455A (en) Mycobacterial nucleic acid hybridization probes and methods of use
KR100388548B1 (ko) 알이피 13 이 12 반복서열의 피시알 증폭을 이용한결핵균의 검출방법
KR100446850B1 (ko) 마이코박테리아의 동정 및 ｒｐｏＢ 유전자의 돌연변이에의해 얻어지는 항 결핵제 내성의 동시 검출방법
US5173401A (en) Detection of neisseria gonorrohoeae
Fries et al. Detection of untreated mycobacteria by using polymerase chain reaction and specific DNA probes
JP2781749B2 (ja) マイコバクテリアの溶菌方法
US5817459A (en) Nucleotide sequences of actinomycetales, oligonucleotides of said sequences and their use for detecting the presence of actinomycetales
Fauville-Dufaux et al. Rapid detection of tuberculous and non-tuberculous mycobacteria by polymerase chain reaction amplification of a 162 bp DNA fragment from antigen 85
US20040110129A1 (en) Multiplex hybridization system for identification of pathogenic mycobacterium and method of use
US5650272A (en) Nucleotide sequences which hybridize specifically with bacterial strains of the mycobacterium avium-intracellulare complex
JP3565752B2 (ja) Ｄｎａジャイレース遺伝子中に存在する特徴的な塩基配列を用いた遅発育性マイコバクテリアの同定法及び特異的検出法
JPS6188900A (ja) 媒質中の所定微生物、特にレギオネラの検出用プロ−ブおよび検出方法
WO1992016652A1 (fr) Sondes d'acide nucleique utilisees pour la detection de mycobacterium tuberculosis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2106869

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1991906228

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1991906228

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1991906228

Country of ref document: EP